Transcriptome alteration in the diabetic heart by rosiglitazone: Implications for cardiovascular mortality

Kitchener D. Wilson; Zongjin Li; Roger Wagner; Patrick Yue; Phillip Tsao; Gergana Nestorova; Mei Huang; David L. Hirschberg; Paul G. Yock; Thomas Quertermous; Joseph C. Wu

doi:10.1371/journal.pone.0002609

Transcriptome alteration in the diabetic heart by rosiglitazone: Implications for cardiovascular mortality

Kitchener D. Wilson
, Zongjin Li
, Roger Wagner
, Patrick Yue
, Phillip Tsao
, Gergana Nestorova
, Mei Huang
, David L. Hirschberg
, Paul G. Yock
, Thomas Quertermous
, Joseph C. Wu

Stanford University School of Medicine
Department of Bioengineering

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	e2609
Journal	PLoS ONE
Volume	3
Issue number	7
DOIs	https://doi.org/10.1371/journal.pone.0002609
State	Published - Jul 9 2008
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus Subject Areas

General

Access to Document

10.1371/journal.pone.0002609

Cite this

@article{d07a6b4e1a9f4e83acc552094319fbae,

title = "Transcriptome alteration in the diabetic heart by rosiglitazone: Implications for cardiovascular mortality",

author = "Wilson, \{Kitchener D.\} and Zongjin Li and Roger Wagner and Patrick Yue and Phillip Tsao and Gergana Nestorova and Mei Huang and Hirschberg, \{David L.\} and Yock, \{Paul G.\} and Thomas Quertermous and Wu, \{Joseph C.\}",

note = "Recently, the type 2 diabetes medication, rosiglitazone, has come under scrutiny for possibly increasing the risk of cardiac disease and death. To investigate the effects of rosiglitazone on the diabetic heart, we performed cardiac transcriptional profiling and imaging studies of a murine model of type 2 diabetes, the C57BL/KLS-lepr db/lepr db ( db/db) mouse.",

year = "2008",

month = jul,

day = "9",

doi = "10.1371/journal.pone.0002609",

language = "English",

volume = "3",

journal = "PLoS ONE",

issn = "1932-6203",

number = "7",

}

TY - JOUR

T1 - Transcriptome alteration in the diabetic heart by rosiglitazone

T2 - Implications for cardiovascular mortality

AU - Wilson, Kitchener D.

AU - Li, Zongjin

AU - Wagner, Roger

AU - Yue, Patrick

AU - Tsao, Phillip

AU - Nestorova, Gergana

AU - Huang, Mei

AU - Hirschberg, David L.

AU - Yock, Paul G.

AU - Quertermous, Thomas

AU - Wu, Joseph C.

N1 - Recently, the type 2 diabetes medication, rosiglitazone, has come under scrutiny for possibly increasing the risk of cardiac disease and death. To investigate the effects of rosiglitazone on the diabetic heart, we performed cardiac transcriptional profiling and imaging studies of a murine model of type 2 diabetes, the C57BL/KLS-lepr db/lepr db ( db/db) mouse.

PY - 2008/7/9

Y1 - 2008/7/9

UR - https://www.scopus.com/pages/publications/50249093156

UR - https://www.scopus.com/pages/publications/50249093156#tab=citedBy

U2 - 10.1371/journal.pone.0002609

DO - 10.1371/journal.pone.0002609

M3 - Article

SN - 1932-6203

VL - 3

JO - PLoS ONE

JF - PLoS ONE

IS - 7

M1 - e2609

ER -

Transcriptome alteration in the diabetic heart by rosiglitazone: Implications for cardiovascular mortality

UN SDGs

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this